… ALI/ARDS is rarely present at the time of hospital admission and … from treatment with
surfactant (78). Possible additional … a heterogeneous group of patients future studies should be …

… activation and injury at the onset of ALI/ARDS may be an … protein components of surfactant
that are characteristic of ALI/ARDS.[… Future therapies aimed at restoring the overall balance of …

… in ALI/ARDS if we can increase our fund of knowledge at the … , MD to consider future
directions in research in ALI/ARDS. … NHLBI in planning future research in ALI/ARDS. This article …

… may provide great promises in treating ARDS in the future. … trial demonstrated that exogenous
surfactant therapy was only … neutrophil overactivation during ALI/ARDS releases cytotoxic …

… in the genetic epidemiology of ALI/ARDS and discuss the relative … the implications for future
prevention and treatment. The possible … to future prevention and treatment of ALI/ARDS are …

… and highlights areas of future perspectives in therapeutics. … The cuboidal type II AECs
secrete a surfactant that is believed … a causal factor for development of ALI/ARDS [51]. However, …

… ARDS, and anticipates future developments in related fields. … The causes of ALI/ARDS are
numerous and include direct … alveoli lead to damage to the surfactant on the alveolar surface, …

… mortality with surfactant therapy in … therapeutic strategy should be developed in the future,
aiming to block or stimulate not only one pathogenic pathway but several relevant pathways at …

… future pharmacologic therapies for acute lung injury and acute respiratory distress syndrome
(ALI/ARDS). … Exogenous surfactant administration has been successfully used in neonatal …

… In this review, ALI/ARDS gene therapy is discussed mainly in … Type II epithelial cells produce
surfactant proteins, which … be reported for the treatment of ALI/ARDS in the near future. …